Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

Clinical trial NCT00942734 · COMPLETED

Trial details

NCT number: NCT00942734
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head And Neck Cancer

Start date: 2009-07-01
Primary completion: 2014-11-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.